Differences in HCV Viral Decline between Low and Standard-Dose Pegylated-Interferon-Alpha-2a with Ribavirin in HIV/HCV Genotype 3 Patients

BACKGROUND: The aim of the study was to analyze the different impact of standard and low-dose Peg-IFN-α2a/RBV therapies on HCV viral decline in HIV/HCV genotype 3 co-infected patients during the first weeks of treatment. METHODS: Plasma HCV viral decline was analyzed between baseline and weeks 1, 2...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Rivero-Juárez, Antonio, Lopez-Cortes, Luis F., Camacho, Angela, Torres-Cornejo, Almudena, Pineda, Juan A., Marquez-Solero, Manuel, Caruz, Antonio, Ruiz-Valderas, Rosa, Torre-Cisneros, Julian, Gutierrez-Valencia, Alicia, Rivero, Antonio
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2012
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3493612/
https://ncbi.nlm.nih.gov/pubmed/23145040
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0048959
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados